Ulisse Biomed S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 0.066208 million. Revenue was EUR 0.263153 million.
Net loss was EUR 4.8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 EUR | 0.00% | -2.16% | -31.72% |
06-13 | Ulisse Biomed and Ikonisys together to innovate oncology diagnostics | AN |
06-12 | Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies | MT |
Ulisse Biomed S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 0.066208 million. Revenue was EUR 0.263153 million.
Net loss was EUR 4.8 million.
1st Jan change | Capi. | |
---|---|---|
-31.72% | 26.36M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |